Seattle biotech startup Tune Therapeutics lands $175M to support clinical research
Tune Therapeutics’ co-founders, from left: Akira Matsuno, chief financial officer; Charles Gersbach; and Fyodor Urnov, who also serves on the startup’s scientific advisory board. (Tune Photos) Tune Therapeutics, a biotech company with headquarters in …